Hyper-sialylated IgG product M-254 well tolerated in healthy subjects in first-in-human trial Dec. 18, 2019
Pharmacokinetic and antidrug antibody status of ABP-959 biosimilar compared to eculizumab Dec. 17, 2019
Phase II trials of concizumab show clinical proof of concept for bleeding prevention in hemophilia Dec. 16, 2019
Novel FVIII mimetic bispecific antibody Mim8 exhibits preclinical efficacy against hemophilia A Dec. 12, 2019
RSS